Pennsylvania Cancer Specialists Research Institute

What Pennsylvania Cancer Specialists Research Institute does

Pennsylvania Cancer Specialists & Research Institute (PCSRI) is a private, physician-founded community oncology practice headquartered in Gettysburg, Pennsylvania, operating across Adams and York County since 1989. The practice delivers comprehensive cancer care, hematology services, diagnostic imaging, infusion therapy, and pharmacy services through three facilities: Gettysburg Cancer Center, Hanover Cancer Center, and Adams Diagnostic Imaging. Clinical capabilities include medical oncology, chemotherapy, immunotherapy, advanced imaging modalities (PET/CT, MRI, CT, X-Ray, Ultrasound, Nuclear Medicine), an on-site infusion treatment center, an in-house pharmacy with a physician dispensing program, a low-dose CT lung cancer screening program, and an active clinical trials portfolio with more than 10 open trials and 15+ years of research experience. The practice is designated a Blue Distinction Cancer Care Center by Capital Blue Cross and holds partnerships with Hershey Medical Center, Johns Hopkins University, and NIH for complex case consultation, alongside a Cancer Support Community affiliation.

PCSRI generates revenue primarily through fee-for-service billing across multiple insurance payors including Medicare, Medicaid, Capital Blue Cross, Aetna, Cigna, Geisinger Health Plan, Humana, UPMC, and United Healthcare, supplemented by self-pay imaging services at Adams Diagnostic Imaging and financial assistance programs via copay foundations. The go-to-market model is community-led, with patient acquisition driven by physician referrals, direct self-referral, and 25+ years of community reputation. The leadership team comprises founder and CEO Dr. Satish Shah and Medical Director Dr. Tina Khair, supported by an in-house social services team handling financial, emotional, transportation, and dietitian support. The organization operates as a founder-owned independent entity with no disclosed private equity backing, parent company, or outside institutional investment, and its careers page is hosted on OneOncology's Workday platform, suggesting an operational affiliation with the national community oncology network.

Name

Pennsylvania Cancer Specialists Research Institute

Legal name

Pennsylvania Cancer Specialists & Research Institute

Website

https://pcsri.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

Pennsylvania Cancer Specialists & Research Institute is a private community oncology practice in Gettysburg, PA providing cancer care, hematology, diagnostic imaging, infusion, pharmacy, and clinical trials to patients across Adams and York County, Pennsylvania since 1989.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Healthcare Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAFAKAB

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)

Healthcare & Life Sciences/Healthcare Providers & Systems/Diagnostic & Imaging Centers

SECONDARYHLAIAGAI

Nuclear Medicine Clinical Services & Therapy Centers

Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine

Keywords

• Oncology services
• Cancer care
• Diagnostic imaging
• Hematology services
• Clinical research

Headquarters

HQ city

Gettysburg

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive oncology and hematology medical services including consultations, treatments, procedures, and follow-up care. Billed through insurance providers and patient payments.
2. Diagnostic Imaging Services: Revenue from advanced imaging services including PET/CT, MRI, CT scans, X-Ray, Ultrasound, and Nuclear Medicine. Offered at affordable prices for insured and self-pay patients at Adams Diagnostic Imaging.
3. Patient Assistance Programs: Financial assistance programs helping patients manage cost-sharing and out-of-pocket expenses through copay foundations and charitable organizations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Pennsylvania Cancer Specialists Research Institute provides comprehensive community-based cancer care, including medical oncology, hematology, diagnostic imaging (PET/CT, MRI, CT, X-Ray, Ultrasound, Nuclear Medicine), an on-site infusion treatment center, an in-house pharmacy, lung cancer screening, social services, and a clinical trials program. Services are delivered across three facilities in Gettysburg and Hanover, Pennsylvania, serving patients in Adams and York Counties for over 25 years.

Product overview

Pennsylvania Cancer Specialists & Research Institute offers a comprehensive, integrated cancer care program under one roof. The organization combines Medical Oncology & Hematology Services, Adams Diagnostic Imaging (providing CT, PET/CT, MRI, X-Ray, Ultrasound, and Nuclear Medicine), an Infusion Treatment Center, and an In-House Pharmacy. Additional services include a Lung Cancer Screening Program, Social Services (financial assistance, emotional support, transportation), and an active Clinical Trials Program with 10+ open trials. The practice serves patients through three locations: Gettysburg Cancer Center, Hanover Cancer Center, and Adams Diagnostic Imaging.

Differentiator

Problem solved

Functional benefit

Brands

• Adams Diagnostic Imaging: ACR certified imaging center in Gettysburg, PA providing PET, CT, MRI, X-Ray, Ultrasound, and Nuclear Medicine services at affordable prices.

Products and services

• Medical Oncology & Hematology Services

Quantifiable outcome

• Early-stage lung cancer is often highly treatable with appropriate screening
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Hershey Medical Center Surgical Oncology DepartmentcoreStrategic or Co-development PartnerStrategic partnership for solid tumor board conferences, providing collaborative case review and treatment planning for complex solid tumor cases through academic-community partnership.
• Johns Hopkins UniversitycoreStrategic or Co-development PartnerCollaboration for complicated patient diagnoses, providing access to academic medical center expertise for complex cancer cases requiring specialized consultation.
• National Institutes of Health (NIH)coreStrategic or Co-development PartnerCollaboration for complicated patient diagnoses, enabling access to cutting-edge research and clinical insights for complex cancer cases.
• Cancer Support CommunitycoreStrategic or Co-development PartnerPartnership with organization having over 175 locations worldwide. Provides patients access to Helpline (free phone support service), Mylifeline.org online support platform, and exceptional support services specifically designed for people undergoing cancer treatment. One of few community oncology practices in the U.S. connected with CSC.

Scale indicators5 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• RAYUS Radiology: Multi-modality outpatient diagnostic imaging network offering PET/CT, MRI, CT, and Nuclear Medicine with similar value-pricing positioning to Adams Diagnostic Imaging; directly comparable to PCSRI's imaging arm.
• Florida Cancer Specialists & Research Institute: Large Florida-based community oncology and hematology practice with an integrated diagnostic imaging arm and active clinical trials program; closest functional analog to PCSRI's vertically integrated, multi-site model (and a near-name match).
• OneOncology: Platform partnership network of independent community oncology practices; PCSRI's careers portal is hosted on OneOncology's Workday, suggesting affiliation. Operates as both peer and potential acquirer given the network structure.
• Tennessee Oncology: Multi-site community oncology practice with infusion, imaging, and clinical research arms across Tennessee; comparable in scale and integrated service model to PCSRI.
• New York Cancer & Blood Specialists: Large multi-location community oncology, hematology, and diagnostic radiology practice with infusion, imaging, and clinical trials; comparable vertically integrated model.
• Northwest Georgia Oncology Centers: Community-based, physician-owned oncology practice offering medical oncology, hematology, infusion, imaging, and clinical trials in a multi-site setting; closely analogous in scope and operating model to PCSRI.
• Regional Cancer Care Associates: Mid-Atlantic and Northeast community oncology and hematology group offering infusion, imaging, and clinical trials; directly comparable in specialty mix and patient base demographics to PCSRI.

Broad incumbents

• The US Oncology Network (McKesson): Nation's largest network of community oncology practices, providing technology, payer contracting, and clinical trials infrastructure to independent sites including PCSRI-comparable practices; relevant as a competitor and as a likely partnership platform.
• Cancer Treatment Centers of America (City of Hope): National specialty oncology provider (now part of City of Hope) operating dedicated cancer hospitals with integrated imaging and clinical research; broader incumbent shaping referral patterns and competitive landscape for community sites like PCSRI.

Regional players

• Astera Cancer Care: New Jersey-based multi-specialty oncology and hematology group with integrated imaging and clinical trials; comparable specialty mix but East Coast/PA-adjacent rather than direct PA competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pcsriofficial
• Facebookfacebook.com/GettysburgCancerCenter
• LinkedInlinkedin.com/company/pennsylvania-cancer-specialists-research-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pennsylvania Cancer Specialists Research Institute